Sarah Kathleen Knutson

USPTO Granted Patents = 31 (Patent Applications = 30)

CIPO Patents = 7 (Patent Applications = 7)

EPO Patents = 12 (Patent Applications = 17)

Average Co-Inventor Count = 4.5

ph-index = 13

Forward Citations = 493(Granted Patents)

Location History:

Cambridge, MA (US) (2014 - 2019)
Lincoln, MA (US) (2019 - 2024)

Company Filing History:

Eisai R&d Management Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12168016 - Aryl-OR heteroaryl-substituted benzene compounds (2024-12-17),

2. 12168015 - Aryl-or heteroaryl-substituted benzene compounds (2024-12-17),

3. 12162865 - Methods of treating cancer (2024-12-10),

4. 12161645 - Aryl-or heteroaryl-substituted benzene compounds (2024-12-10),

5. 11951109 - EZH2 inhibitors for treating lymphoma (2024-04-09),

6. 11642349 - Method for treating cancer (2023-05-09),

7. 11642347 - EZH2 inhibitors for treating lymphoma (2023-05-09),

8. 11370781 - Combination therapy for treating cancer (2022-06-28),

9. 11202781 - EZH2 inhibitors for treating lymphoma (2021-12-21),

10. 11052093 - Aryl-or heteroaryl-substituted benzene compounds (2021-07-06),

11. 10898490 - Method for treating cancer (2021-01-26),

12. 10787440 - Combination therapy for treating cancer (2020-09-29),

13. 10493076 - Method for treating cancer (2019-12-03),

14. 10463671 - Combination therapy for treating cancer (2019-11-05),

15. 10420775 - Aryl-or heteroaryl-substituted benzene compounds (2019-09-24),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I am happy to assist you in crafting an article about inventor Sarah Kathleen Knutson.

Title: Sarah Kathleen Knutson: Leading the Way in Innovation and Invention

Introduction:

Sarah Kathleen Knutson, a visionary inventor based in Cambridge, MA, is a true trailblazer in the realm of invention. With a deep passion for innovation and a relentless dedication to pushing the boundaries of technology, she continues to inspire the next generation of inventors and shape the future of technology.

Latest Patents:

With an impressive portfolio of 26 patents, Sarah Kathleen Knutson's latest inventions include a "Method for treating cancer" and "EZH2 Inhibitors for treating lymphoma." These groundbreaking pharmaceutical compositions and treatment methods showcase her commitment to advancing cancer therapy.

Career Highlights:

Sarah Kathleen Knutson has made significant contributions to the field of invention through her work at Epizyme, Inc., and Eisai R&D Management Co., Ltd. Her innovative thinking and collaborative efforts have led to the development of novel technologies that have the potential to revolutionize the healthcare industry.

Collaborations:

Throughout her career, Sarah Kathleen Knutson has collaborated with esteemed professionals in the field, including Heike Keilhack and Kevin Wayne Kuntz. These collaborations have not only enhanced the quality of her inventions but have also fostered a culture of innovation and excellence.

Conclusion:

In conclusion, Sarah Kathleen Knutson's exceptional talent, coupled with her unwavering commitment to innovation, has established her as a pioneering force in the world of invention. Her contributions to the field continue to inspire and shape the future of technology, making her a true luminary in the realm of innovation.

This text is generated by artificial intelligence and may not be accurate.